CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$1.14
+11.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 11.00x
- P/E 2028E
- 2.39x
- P/S forward
- 1.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.62x
- Price / sales
- 14.92x
- Price / cash flow
- -5.38x
Enterprise value
- Enterprise value
- $99.6M
- EV / sales
- 14.02x
- EV / EBITDA
- -2.31x
- EV / EBIT
- -2.11x
- Market cap
- $106.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026